Underlying mechanisms of ovarian cancer risk reduction after tubal ligation

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 6, 2011, Pages 559-563

  Cibula, David ^a   Widschwendter, Martin ^b   Zikan, Michael ^a   Dusek, Ladislav ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cancer prevention; ovarian cancer; tubal ligation

Indexed keywords

BRCA1 PROTEIN; CARCINOGEN; ESTRADIOL; ESTROGEN; HOX PROTEIN; LUTEINIZING HORMONE; PREGNANEDIOL; PROGESTERONE; PROTEIN P53; TRANSCRIPTION FACTOR HOXA9;

CANCER RISK; COMPARATIVE STUDY; DNA METHYLATION; ENDOMETRIUM; ENDOMETRIUM CELL; EPITHELIUM TUMOR; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FERTILE PERIOD; GENE MUTATION; HORMONE SYNTHESIS; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; META ANALYSIS (TOPIC); OVARY CANCER; OVARY FUNCTION; OVARY INSUFFICIENCY; PERITONEAL CAVITY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN METHYLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; UTERINE ENDOCERVIX; UTERINE TUBE; UTERINE TUBE LIGATION;

CARCINOGENS; CELL MOVEMENT; FEMALE; HUMANS; KINETICS; MASS SCREENING; MECHANICAL PROCESSES; OVARIAN NEOPLASMS; OVARY; PRIMARY PREVENTION; RISK REDUCTION BEHAVIOR; STERILIZATION, TUBAL; TIME FACTORS;

EID: 79956187753     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01114.x     Document Type: Review

References (54)

1. Shu XO, Brinton LA, Gao YT, Yuan JM,. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res. 1989; 49: 3670-4. (Pubitemid 19178194)
2. Rosenblatt KA, Thomas DB,. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 1996; 5: 933-5.
3. Cornelison TL, Natarajan N, Piver MS, Mettlin CJ,. Tubal ligation and the risk of ovarian carcinoma. Cancer Detect Prev. 1997; 21: 1-6. (Pubitemid 27307064)
4. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, et al,. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer. 1997; 71: 948-51. (Pubitemid 27252873)
5. Kjaer SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH,. Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65,000 sterilized women. Int J Epidemiol. 2004; 33: 596-602. (Pubitemid 38997237)
6. Cibula D, Widschwendter M, Majek O, Dusek L,. Tubal ligation and the risk of ovarian cancer-review and meta-analysis. Hum Reprod Update. 2011; 17: 55-67.
7. Wahlberg C,. Tubal ligation, hysterectomy, and risk of ovarian cancer. J Am Med Assoc. 1994; 271: 1236; author reply 1236-7.
8. Cramer DW, Welch WR, Scully RE, Wojciechowski CA,. Ovarian cancer and talc: a case-control study. Cancer. 1982; 50: 372-6. (Pubitemid 12089403)
9. Huncharek M, Geschwind JF, Kupelnick B,. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: A meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res. 2003; 23: 1955-60. (Pubitemid 36750874)
10. Cheng W, Liu J, Yoshida H, Rosen D, Naora H,. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med. 2005; 11: 531-7. (Pubitemid 40685976)
11. Widschwendter M, Apostolidou S, Jones AA, Fourkala EO, Arora R, Pearce CL, et al,. HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study. Int J Cancer. 2009; 125: 2214-8.
12. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR,. Case-control study of borderline ovarian tumors: Reproductive history and exposure to exogenous female hormones. Cancer Res. 1988; 48: 5849-52.
13. Whittemore AS, Wu ML, Paffenbarger RS Jr, Sarles DL, Kampert JB, Grosser S, et al,. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol. 1988; 128: 1228-40. (Pubitemid 19015496)
14. Irwin KL, Weiss NS, Lee NC, Peterson HB,. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol. 1991; 134: 362-9.
15. Kreiger N, Sloan M, Cotterchio M, Parsons P,. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol. 1997; 26: 710-5. (Pubitemid 27367845)
16. Miracle-McMahill HL, Calle EE, Kosinski AS, Rodriguez C, Wingo PA, Thun MJ, et al,. Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol. 1997; 145: 349-57. (Pubitemid 27082034)
17. Cattanach J,. Oestrogen deficiency after tubal ligation. Lancet. 1985; i: 847-9. (Pubitemid 15115119)
18. Hankinson SE, Hunter DJ, Colditz GA, Willett WC, Stampfer MJ, Rosner B, et al,. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. J Am Med Assoc. 1993; 270: 2813-8. (Pubitemid 23361643)
19. Peterson HB, Jeng G, Folger SG, Hillis SA, Marchbanks PA, Wilcox LS,. The risk of menstrual abnormalities after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med. 2000; 343: 1681-7.
20. Harris R, Whittemore AS, Itnyre J,. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 1204-11. (Pubitemid 23026891)
21. Whittemore AS, Harris R, Itnyre J, Halpern J,. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 1175-83. (Pubitemid 23026889)
22. Whittemore AS, Harris R, Itnyre J,. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 1184-203. (Pubitemid 23026890)
23. Whittemore AS, Harris R, Itnyre J,. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992; 136: 1212-20. (Pubitemid 23026892)
24. Alvarez-Sanchez F, Segal SJ, Brache V, Adejuwon CA, Leon P, Faundes A,. Pituitary-ovarian function after tubal ligation. Fertil Steril. 1981; 36: 606-9. (Pubitemid 12228305)
25. Corson SL, Levinson CJ, Batzer FR, Otis C,. Hormonal levels following sterilization and hysterectomy. J Reprod Med. 1981; 26: 363-70. (Pubitemid 12234574)
26. Sorensen T, Ladehoff P, Lindholm P, Qvist K,. Follicular stimulating hormone, luteinizing hormone and estrogen levels before and after female sterilization. Acta Obstet Gynecol Scand. 1981; 60: 559-61. (Pubitemid 12219095)
27. Radwanska E, Berger GS, Hammond J,. Luteal deficiency among women with normal menstrual cycles, requesting reversal of tubal sterilization. Obstet Gynecol. 1979; 54: 189-92. (Pubitemid 9206150)
28. Donnez J, Wauters M, Thomas K,. Luteal function after tubal sterilization. Obstet Gynecol. 1981; 57: 65-8. (Pubitemid 11213550)
29. Radwanska E, Headley SK, Dmowski P,. Evaluation of ovarian function after tubal sterilization. J Reprod Med. 1982; 27: 376-84. (Pubitemid 12048318)
30. Helm G, Sjoberg NO,. Progesterone levels before and after laparoscopic tubal sterilization using endotherm coagulation. Acta Obstet Gynecol Scand. 1983; 62: 63-6. (Pubitemid 13119938)
31. Rivera R, Gaitan JR, Ruiz R, Hurley DP, Arenas M, Flores C, et al,. Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion. Contraception. 1989; 40: 157-69.
32. Garza-Flores J, Vázquez-Estrada L, Reyes A, Valero A, Morales Del Olmo A, Alba VM, et al,. Assessment of luteal function after surgical tubal sterilization. Adv Contracept. 1991; 7: 371-7.
33. Wu E, Xiao B, Yan W, Li H, Wu B,. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization. Contraception. 1992; 45: 583-93.
34. Williams EL, Jones HE, Merrill RE,. The subsequent course of patients sterilized by tubal ligation; a consideration of hysterectomy for sterilization. Am J Obstet Gynecol. 1951; 61: 423-6.
35. Neil JR, Hammond GT, Noble AD, Rushton L, Letchworth AT,. Late complications of sterilisation by laparoscopy and tubal ligation. A controlled study. Lancet. 1975; ii: 699-700.
36. DeStefano F, Huezo CM, Peterson HB, Rubin GL, Layde PM, Ory HW,. Menstrual changes after tubal sterilization. Obstet Gynecol. 1983; 62: 673-81. (Pubitemid 14201597)
37. DeStefano F, Perlman JA, Peterson HB, Diamond EL,. Long-term risk of menstrual disturbances after tubal sterilization. Am J Obstet Gynecol. 1985; 152: 835-41. (Pubitemid 15016513)
38. Rulin MC, Davidson AR, Philliber SG, Graves WL, Cushman LF,. Changes in menstrual symptoms among sterilized and comparison women: a prospective study. Obstet Gynecol. 1989; 74: 149-54. (Pubitemid 19184802)
39. Gentile GP, Helbig DW, Zacur H, Park T, Lee YJ, Westhoff CL,. Hormone levels before and after tubal sterilization. Contraception. 2006; 73: 507-11.
40. Dede FS, Dilbaz B, Akyuz O, Caliskan E, Kurtaran V, Dilbaz S,. Changes in menstrual pattern and ovarian function following bipolar electrocauterization of the fallopian tubes for voluntary surgical contraception. Contraception. 2006; 73: 88-91. (Pubitemid 41811196)
41. Egli GE, Newton M,. The transport of carbon particles in the human female reproductive tract. Fertil Steril. 1961; 12: 151-5.
42. Longo DL, Young RC,. Cosmetic talc and ovarian cancer. Lancet. 1979; ii: 349-51. (Pubitemid 9243786)
43. Harlow BL, Cramer DW, Bell DA, Welch WR,. Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol. 1992; 80: 19-26.
44. Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA,. Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol. 1992; 21: 23-9.
45. Mills PK, Riordan DG, Cress RD, Young HA,. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California. Int J Cancer. 2004; 112: 458-64. (Pubitemid 39390611)
46. Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC,. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer. 2008; 44: 2477-84.
47. Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, et al,. Prospective study of talc use and ovarian cancer. J Natl Cancer Inst. 2000; 92: 249-52. (Pubitemid 30099784)
48. Dubeau L,. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008; 9: 1191-7.
49. Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ,. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009; 33: 1878-85.
50. Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, et al,. Serous tubal intraepithelial carcinoma: its potential role in primary peritonealserous carcinoma and serous cancer prevention. J Clin Oncol. 2008; 26: 4160-5.
51. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT,. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol. 2004; 191: 733-40. (Pubitemid 39298101)
52. Parazzini F, Negri E, La Vecchia C, et al,. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet Gynecol. 1993; 81: 363-6. (Pubitemid 23085291)
53. Modugno F, Ness RB, Wheeler JE,. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol. 2001; 11: 568-74. (Pubitemid 33049892)
54. Dubeau L,. Brca1-induced ovarian oncogenesis. Adv Exp Med Biol. 2008; 622: 89-97.